Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1Christina W. Yde, Olaf‐Georg Issinger|International Journal of Oncology|2006Cited by 72
A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytomaChristina W. Yde, Maria Rossing|Cancer Genetics|2016Cited by 38
Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor αASTRID M. PEDERSEN, Christina W. Yde|International Journal of Oncology|2014Cited by 19